The U.S. Food and Drug Administration (FDA) on Thursday approved the medication Exxua to treat major depressive disorder – a significant step after a decades-long battle for approval. Exxua is unique for its ability to target the serotonin 1A receptor, which is a regulator of mood and emotion. In doing so, it avoids undesirable side… Source
Related posts:
Eleven workers rescued from China mine after being trapped for two weeks
"You Are Not The People, You Are The Past" Public Broadcaster Tells German Critics Of Mass...
Things Get Messi After Argentina Cancels Soccer Match with Israel
New Dad Recovering After Spending Night On Uncomfortable Hospital Bench With Limited Snacks
Israeli air force pilot and cadet laid to rest after deadly training crash
World’s Largest Games Vendor Zaps $60 Billion After China Media Labels It ‘Spiritual Opium’
Views: 0